Margaret G. McGlynn, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 20,000 shares at $160.00 ($3.3M) on 2018-01-22, disclosed to the SEC on 2018-01-24.
Open-market sale of $3.2M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $160.00 | 10,000 | $1.6M | 49.2% |
| 2 | $165.00 | 10,000 | $1.6M | 50.8% |
| Total | $162.50 avg | 20,000 | $3.3M | 100% |
| Filing → |
| FOLD | SELL | 2022-05-04 | $105K | — | Filing → |
| VRTX | SELL | 2022-04-12 | $1.4M | — | Filing → |
| VRTX | SELL | 2022-04-04 | $2.6M | — | Filing → |